Doctors on Monday gave longer is because of a landmark study showing that stomach-reducing operations are superior to medications for the treatment of "diabesity," the deadly duo of obesity and kind 2 diabetes. Countless Americans have this and meizitang can't make enough insulin or make use of the things they're doing make to process food.

Many experts were skeptical the advantages seen following a year would last.

Now, three-year results show an even greater advantage for surgery.

Blood-sugar levels were normal in 38 percent and A quarter of two groups given surgery, however in only 5 % of these given medications.

The final results are "quite remarkable" and could revolutionize care, said one independent expert, Dr. Robert Siegel, a cardiologist at Cedars-Sinai Medical Center in La.

"No one dreamed, at least I did not," that obesity surgery might have such broad effects well before it caused patients to lose weight, he explained. Some meizitang soft gel patients were able to stop using insulin a couple of days after surgery.

At 3 years, "more than Ninety percent in the surgical patients required no insulin," and up to 50 % had needed it at the beginning of the research, said its leader, Dr. Philip Schauer of the Cleveland Clinic. In comparison, insulin use rose within the medication group, from 52 percent in the beginning to 55 percent at three years.